Cargando…
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117132/ https://www.ncbi.nlm.nih.gov/pubmed/35484266 http://dx.doi.org/10.1038/s41591-022-01827-x |
| _version_ | 1784710264432623616 |
|---|---|
| author | Ganan-Gomez, Irene Yang, Hui Ma, Feiyang Montalban-Bravo, Guillermo Thongon, Natthakan Marchica, Valentina Richard-Carpentier, Guillaume Chien, Kelly Manyam, Ganiraju Wang, Feng Alfonso, Ana Chen, Shuaitong Class, Caleb Kanagal-Shamanna, Rashmi Ingram, Justin P. Ogoti, Yamini Rose, Ashley Loghavi, Sanam Lockyer, Pamela Cambo, Benedetta Muftuoglu, Muharrem Schneider, Sarah Adema, Vera McLellan, Michael Garza, John Marchesini, Matteo Giuliani, Nicola Pellegrini, Matteo Wang, Jing Walker, Jason Li, Ziyi Takahashi, Koichi Leverson, Joel D. Bueso-Ramos, Carlos Andreeff, Michael Clise-Dwyer, Karen Garcia-Manero, Guillermo Colla, Simona |
| author_facet | Ganan-Gomez, Irene Yang, Hui Ma, Feiyang Montalban-Bravo, Guillermo Thongon, Natthakan Marchica, Valentina Richard-Carpentier, Guillaume Chien, Kelly Manyam, Ganiraju Wang, Feng Alfonso, Ana Chen, Shuaitong Class, Caleb Kanagal-Shamanna, Rashmi Ingram, Justin P. Ogoti, Yamini Rose, Ashley Loghavi, Sanam Lockyer, Pamela Cambo, Benedetta Muftuoglu, Muharrem Schneider, Sarah Adema, Vera McLellan, Michael Garza, John Marchesini, Matteo Giuliani, Nicola Pellegrini, Matteo Wang, Jing Walker, Jason Li, Ziyi Takahashi, Koichi Leverson, Joel D. Bueso-Ramos, Carlos Andreeff, Michael Clise-Dwyer, Karen Garcia-Manero, Guillermo Colla, Simona |
| author_sort | Ganan-Gomez, Irene |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9117132 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91171322022-05-20 Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy Ganan-Gomez, Irene Yang, Hui Ma, Feiyang Montalban-Bravo, Guillermo Thongon, Natthakan Marchica, Valentina Richard-Carpentier, Guillaume Chien, Kelly Manyam, Ganiraju Wang, Feng Alfonso, Ana Chen, Shuaitong Class, Caleb Kanagal-Shamanna, Rashmi Ingram, Justin P. Ogoti, Yamini Rose, Ashley Loghavi, Sanam Lockyer, Pamela Cambo, Benedetta Muftuoglu, Muharrem Schneider, Sarah Adema, Vera McLellan, Michael Garza, John Marchesini, Matteo Giuliani, Nicola Pellegrini, Matteo Wang, Jing Walker, Jason Li, Ziyi Takahashi, Koichi Leverson, Joel D. Bueso-Ramos, Carlos Andreeff, Michael Clise-Dwyer, Karen Garcia-Manero, Guillermo Colla, Simona Nat Med Author Correction Nature Publishing Group US 2022-04-28 2022 /pmc/articles/PMC9117132/ /pubmed/35484266 http://dx.doi.org/10.1038/s41591-022-01827-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Ganan-Gomez, Irene Yang, Hui Ma, Feiyang Montalban-Bravo, Guillermo Thongon, Natthakan Marchica, Valentina Richard-Carpentier, Guillaume Chien, Kelly Manyam, Ganiraju Wang, Feng Alfonso, Ana Chen, Shuaitong Class, Caleb Kanagal-Shamanna, Rashmi Ingram, Justin P. Ogoti, Yamini Rose, Ashley Loghavi, Sanam Lockyer, Pamela Cambo, Benedetta Muftuoglu, Muharrem Schneider, Sarah Adema, Vera McLellan, Michael Garza, John Marchesini, Matteo Giuliani, Nicola Pellegrini, Matteo Wang, Jing Walker, Jason Li, Ziyi Takahashi, Koichi Leverson, Joel D. Bueso-Ramos, Carlos Andreeff, Michael Clise-Dwyer, Karen Garcia-Manero, Guillermo Colla, Simona Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| title | Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| title_full | Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| title_fullStr | Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| title_full_unstemmed | Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| title_short | Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| title_sort | author correction: stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117132/ https://www.ncbi.nlm.nih.gov/pubmed/35484266 http://dx.doi.org/10.1038/s41591-022-01827-x |
| work_keys_str_mv | AT ganangomezirene authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT yanghui authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT mafeiyang authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT montalbanbravoguillermo authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT thongonnatthakan authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT marchicavalentina authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT richardcarpentierguillaume authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT chienkelly authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT manyamganiraju authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT wangfeng authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT alfonsoana authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT chenshuaitong authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT classcaleb authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT kanagalshamannarashmi authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT ingramjustinp authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT ogotiyamini authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT roseashley authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT loghavisanam authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT lockyerpamela authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT cambobenedetta authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT muftuoglumuharrem authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT schneidersarah authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT ademavera authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT mclellanmichael authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT garzajohn authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT marchesinimatteo authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT giulianinicola authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT pellegrinimatteo authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT wangjing authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT walkerjason authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT liziyi authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT takahashikoichi authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT leversonjoeld authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT buesoramoscarlos authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT andreeffmichael authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT clisedwyerkaren authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT garciamaneroguillermo authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy AT collasimona authorcorrectionstemcellarchitecturedrivesmyelodysplasticsyndromeprogressionandpredictsresponsetovenetoclaxbasedtherapy |